224 related articles for article (PubMed ID: 21416942)
1. [Soluble epoxide hydrolase and lipid metabolism].
Ma XX; Liu Y; Zhu Y
Sheng Li Ke Xue Jin Zhan; 2010 Aug; 41(4):267-71. PubMed ID: 21416942
[TBL] [Abstract][Full Text] [Related]
2. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase: a promising therapeutic target for cardiovascular diseases.
Ni GH; Chen JF; Chen XP; Yang TL
Pharmazie; 2011 Mar; 66(3):153-7. PubMed ID: 21553642
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase: a novel target for the treatment of hypertension.
Fang X
Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):67-72. PubMed ID: 18221075
[TBL] [Abstract][Full Text] [Related]
5. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
Noh MR; Jang HS; Salem FE; Ferrer FA; Kim J; Padanilam BJ
Am J Physiol Renal Physiol; 2023 Feb; 324(2):F138-F151. PubMed ID: 36475868
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450-dependent eicosanoid production and crosstalk.
Fleming I
Curr Opin Lipidol; 2011 Oct; 22(5):403-9. PubMed ID: 21825980
[TBL] [Abstract][Full Text] [Related]
7. Soluble epoxide hydrolase inhibitors and heart failure.
Qiu H; Li N; Liu JY; Harris TR; Hammock BD; Chiamvimonvat N
Cardiovasc Ther; 2011 Apr; 29(2):99-111. PubMed ID: 20433684
[TBL] [Abstract][Full Text] [Related]
8. Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase.
Luria A; Morisseau C; Tsai HJ; Yang J; Inceoglu B; De Taeye B; Watkins SM; Wiest MM; German JB; Hammock BD
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E375-83. PubMed ID: 19458064
[TBL] [Abstract][Full Text] [Related]
9. Soluble epoxide hydrolase: A potential target for metabolic diseases.
He J; Wang C; Zhu Y; Ai D
J Diabetes; 2016 May; 8(3):305-13. PubMed ID: 26621325
[TBL] [Abstract][Full Text] [Related]
10. Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth.
Oguro A; Sakamoto K; Suzuki S; Imaoka S
Biol Pharm Bull; 2009 Dec; 32(12):1962-7. PubMed ID: 19952412
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man.
Revermann M
Curr Opin Pharmacol; 2010 Apr; 10(2):173-8. PubMed ID: 20079692
[TBL] [Abstract][Full Text] [Related]
12. Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis.
Enayetallah AE; Grant DF
Biochem Biophys Res Commun; 2006 Mar; 341(1):254-60. PubMed ID: 16414022
[TBL] [Abstract][Full Text] [Related]
13. Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues.
Enayetallah AE; French RA; Barber M; Grant DF
J Histochem Cytochem; 2006 Mar; 54(3):329-35. PubMed ID: 16314446
[TBL] [Abstract][Full Text] [Related]
14. Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases.
Duflot T; Roche C; Lamoureux F; Guerrot D; Bellien J
Expert Opin Drug Discov; 2014 Mar; 9(3):229-43. PubMed ID: 24490654
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.
Ai D; Fu Y; Guo D; Tanaka H; Wang N; Tang C; Hammock BD; Shyy JY; Zhu Y
Proc Natl Acad Sci U S A; 2007 May; 104(21):9018-23. PubMed ID: 17495027
[TBL] [Abstract][Full Text] [Related]
16. Epoxide hydrolase activities and epoxy fatty acids in the mosquito Culex quinquefasciatus.
Xu J; Morisseau C; Yang J; Mamatha DM; Hammock BD
Insect Biochem Mol Biol; 2015 Apr; 59():41-9. PubMed ID: 25686802
[TBL] [Abstract][Full Text] [Related]
17. Eicosanoid imbalance in the NOD mouse is related to a dysregulation in soluble epoxide hydrolase and 15-PGDH expression.
Rodriguez M; Clare-Salzler M
Ann N Y Acad Sci; 2006 Oct; 1079():130-4. PubMed ID: 17130543
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor.
Smith KR; Pinkerton KE; Watanabe T; Pedersen TL; Ma SJ; Hammock BD
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2186-91. PubMed ID: 15684051
[TBL] [Abstract][Full Text] [Related]
19. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.
Imig JD
Cardiovasc Drug Rev; 2006; 24(2):169-88. PubMed ID: 16961727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
